US 7723096
Agonist peptides of carcinoembryonic antigen (CEA) and nucleic acid sequences encoding the agonist peptides
granted A61KA61K38/00A61K39/00
Quick answer
US patent 7723096 (Agonist peptides of carcinoembryonic antigen (CEA) and nucleic acid sequences encoding the agonist peptides) held by The United States of America, as represented by the Department of Health and Human Services expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K38/00, A61K39/00, A61K48/00, A61P